Didier Samuel
Didier Samuel
AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, F-94800, France ; Univ Paris-Sud, UMR-S 785, Villejuif, F-94800
Verified email at pbr.aphp.fr
Title
Cited by
Cited by
Year
International network of cancer genome projects
International Cancer Genome Consortium
Nature 464 (7291), 993, 2010
17992010
Liver transplantation in European patients with the hepatitis B surface antigen
D Samuel, R Muller, G Alexander, L Fassati, B Ducot, JP Benhamou, ...
New England Journal of Medicine 329 (25), 1842-1847, 1993
11611993
Statements from the Taormina expert meeting on occult hepatitis B virus infection
G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ...
Journal of hepatology 49 (4), 652-657, 2008
9932008
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
SK Sarin, A Kumar, JA Almeida, YK Chawla, ST Fan, H Garg, HJ de Silva, ...
Hepatology international 3 (1), 269-282, 2009
9452009
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
S Paramsothy, MA Kamm, NO Kaakoush, AJ Walsh, J van den Bogaerde, ...
The Lancet 389 (10075), 1218-1228, 2017
6952017
Early liver transplantation for severe alcoholic hepatitis
P Mathurin, C Moreno, D Samuel, J Dumortier, J Salleron, F Durand, ...
New England Journal of Medicine 365 (19), 1790-1800, 2011
6882011
EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version)
R De Franchis, A Hadengue, G Lau, D Lavanchy, A Lok, N McIntyre, ...
Journal of Hepatology 39 (SUPPL. 1), 2003
675*2003
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
S Champiat, O Lambotte, E Barreau, R Belkhir, A Berdelou, F Carbonnel, ...
Annals of Oncology 27 (4), 559-574, 2016
6552016
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection
European FK506 Multicentre Liver Study Group
The Lancet 344 (8920), 423-428, 1994
6521994
EASL clinical practice guidelines: liver transplantation
P Burra, A Burroughs, I Graziadei, J Pirenne, JC Valdecasas, P Muiesan, ...
Journal of hepatology 64 (2), 433-485, 2016
587*2016
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre–and post–liver transplantation patients
ER Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ...
Hepatology 38 (6), 1419-1427, 2003
5722003
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study
R Moreau, F Durand, T Poynard, C Duhamel, JP Cervoni, P Ichaï, ...
Gastroenterology 122 (4), 923-930, 2002
5562002
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure
R Jalan, F Saliba, M Pavesi, A Amoros, R Moreau, P Ginès, E Levesque, ...
Journal of hepatology 61 (5), 1038-1047, 2014
5502014
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)–NCT01514890
C Hézode, H Fontaine, C Dorival, D Larrey, F Zoulim, V Canva, ...
Journal of hepatology 59 (3), 434-441, 2013
5212013
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014
SK Sarin, CK Kedarisetty, Z Abbas, D Amarapurkar, C Bihari, AC Chan, ...
Hepatology international 8 (4), 453-471, 2014
5002014
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
R Adam, D Azoulay, D Castaing, R Eshkenazy, G Pascal, K Hashizume, ...
Annals of surgery 238 (4), 508, 2003
4692003
Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients
D Samuel, H Bismuth, A Bismuth, JL Arulnaden, D Mathieu, M Reynes, ...
The Lancet 337 (8745), 813-815, 1991
4481991
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 …
M Manns, D Samuel, EJ Gane, D Mutimer, G McCaughan, M Buti, ...
The Lancet Infectious Diseases 16 (6), 685-697, 2016
4262016
Clinical course of acute‐on‐chronic liver failure syndrome and effects on prognosis
T Gustot, J Fernandez, E Garcia, F Morando, P Caraceni, C Alessandria, ...
Hepatology 62 (1), 243-252, 2015
4172015
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma …
V Vilgrain, H Pereira, E Assenat, B Guiu, AD Ilonca, GP Pageaux, A Sibert, ...
The Lancet Oncology 18 (12), 1624-1636, 2017
4152017
The system can't perform the operation now. Try again later.
Articles 1–20